Skip to main content
FDA approves Allergan's schizophrenia, bipolar I disorder drug
11/14/2017

The FDA approved Allergan's Vraylar, or cariprazine, for use as a maintenance treatment for adult patients with schizophrenia and as an acute treatment of manic or mixed episodes of bipolar I disorder.

Full Story: